የ N-terminal glycine-የያዙ peptides የተመረጠ ማሻሻያ እና የተመሳሰለ የፍሎረሰንት መለያ: የህይወት ሳይንስ ምርምርን ለማብራት አዳዲስ መሳሪያዎች

የ N-terminal glycine-የያዙ peptides የተመረጠ ማሻሻያ እና የተመሳሰለ የፍሎረሰንት መለያ: የህይወት ሳይንስ ምርምርን ለማብራት አዳዲስ መሳሪያዎች


Peptides በህይወት እንቅስቃሴዎች ውስጥ አስፈላጊ ተሳታፊዎች ናቸው, እና የእነሱ ልዩ ማሻሻያ እና መለያ አወቃቀራቸውን እና ተግባራቸውን ለማጥናት አስፈላጊ ናቸው. Over the past decade, methods have been developed to label glycine on α-carbon. ቢሆንም, these methods require pre-functionalization of glycine, which is not possible for rapid recognition of natural amino acids.In this study, we report the dual activation of the α-methylene of glycine, which distinguishes this glycine from 19 other amino acids.

Technical Advantages

Specific selectivity, utilizing the unique chemical properties of N-terminal glycine to realize its specific reaction with modifying reagents and avoid the interference of other amino acid residues.

  • Universal: Applicable to a wide range of N-terminal glycine-containing peptides, as well as different modification groups and fluorescent dyes.
  • Wide range of applications: Provide a powerful tool for peptide structure and function studies, drug screening, bio-imaging and other fields.


This study provides a method for selective labeling of N-terminal glycine peptides using 1,3-diphenyl 1,3-diones to provide pyrrole-based fluorescent products. It is strictly selective for N-terminal glycine due to the “dual activation” mechanism. It provides a theoretical basis for customized N-glycine-based fluorescence modification and a stability test method for rapid identification of N-terminal glycine-containing peptides.

አስተዳዳሪ አቫታር

Bingyan Gao

Quality and Analytical Technician ኮር ኤክስፐርት: Separation and identification of trace impurities, HPLC/MS method development, chiral purity analysis, and compliance with international pharmacopoeias.

Profile: Bingyan Gao is the “ultimate gatekeeper” of peptide purity and quality. He is proficient in the use of various high-end analytical instruments and specializes in developing customized chromatographic separation methods for highly complex modified peptides. He has established a rigorous impurity profiling system that not only ensures product purity of 99% or higher but also precisely identifies and eliminates trace impurities that could cause immunogenicity. With a deep understanding of FDA and EMA regulatory requirements for peptide drugs, he ensures that every batch released from the facility is accompanied by a comprehensive and authoritative Certificate of Analysis (COA).

እውነታ ተረጋግጧል & የአርትዖት መመሪያዎች
የተገመገመው በ: ርዕሰ ጉዳይ ባለሙያዎች
ይህን ጽሑፍ አጋራ
ቤት ፈልግ WhatsApp አገልግሎቶች ምርት